Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to $145.2 million.

  • Vanda Pharmaceuticals' Total Current Liabilities rose 4518.96% to $145.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $145.2 million, marking a year-over-year increase of 4518.96%. This contributed to the annual value of $145.2 million for FY2025, which is 4518.96% up from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Total Current Liabilities of $145.2 million as of Q4 2025, which was up 4518.96% from $117.9 million recorded in Q3 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Total Current Liabilities registered a high of $145.2 million during Q4 2025, and its lowest value of $61.8 million during Q1 2021.
  • Its 5-year average for Total Current Liabilities is $93.1 million, with a median of $91.1 million in 2022.
  • Per our database at Business Quant, Vanda Pharmaceuticals' Total Current Liabilities skyrocketed by 4686.97% in 2022 and then crashed by 840.61% in 2023.
  • Quarter analysis of 5 years shows Vanda Pharmaceuticals' Total Current Liabilities stood at $74.4 million in 2021, then rose by 22.87% to $91.4 million in 2022, then decreased by 4.09% to $87.7 million in 2023, then increased by 14.01% to $100.0 million in 2024, then surged by 45.19% to $145.2 million in 2025.
  • Its Total Current Liabilities stands at $145.2 million for Q4 2025, versus $117.9 million for Q3 2025 and $121.5 million for Q2 2025.